Infliximab, a monoclonal antibody that targets tumor necrosis factor alpha (TNFα), has also been radiolabeled with 99mTc, which demonstrated a superior sensitivity to inflammation than MRI and clinical examinations in patients with RA [107,108,109]. This evidence concerns the gene TNF and rheumatoid arthritis.